This implies that maintaining a high CD4 count through HAART is crucial to prevent anaemia in HIV-positive children Similarly, children who were in WHO clinical stages III and IV were around eight (AOR 7⋅9; 95 % CI 3⋅5, 17⋅91) and (AOR 7⋅8; 95 % CI 3⋅37, 18⋅1) times higher likelihood of being anaemic than those who were in WHO clinical stage I, respectively. Here, CD4 is linked to anemia (phenotype).